They have to reveal lawsuits to all stakeholders though, and shareholders are definately stakeholders. I think the three straight years of getting crls have taken a toll on the stock. But if it gets approval 7 Nov. It may go parabolic. That is the upside of this situation. Lets pray for some luck from god on this one. I am not totally convinced.

This is a $6 stock if it gets approval. I hope they fixed their manufacturing issues. I dont see why thats so hard when they can out-souce
it to a company that makes medicines.

bob, go fight with someone else. CLSD isnt worth the trouble. See how long it took me to respond. I dont own this stock or want it.

I think the huge float is creating drag on the share price. 650 million shares is a lot. Also CEO may not give a crap about investor value.

good info

FDA has been on a rampage this year. Get your principal back. I dont trust CEO's too much. I buy the options.

you cover your position. talk is cheap.

Bob my forte' is options only. The more you guys buy the better it is for me to sell my options at a profit. I dont like shares.

get your principal back first then worry about profits so you shield yourself and live to battle again. You cannot have it all.

I like your time estimate. Thkx.

I came across this stock on seeking alpha. I really look forward to getting paid by this one in my bday in October. GLTA here, Go Mannkind.

After Friday the 13th, I am not worried about capital gains anymore lol.

This drubbing just made me a much better trader. I will not forget it.

They could not have been blind sided, SESN owns the study data and they knew if it was a good candidate or not by phase 1 or 2.

you can still sell in the post market up until 8pm tonight. but this thing
is low low right now

bad study data is not a surprise. I had to be there a time long ago.

If you said folks, "the company is keeping their bad study data secret" That would have given me pause and sent me looking for evidence. Look at the context of how you said it. But you did warn, so appreciated for the next run. And there will be a next run somewhere else.

I lost 14K in options here. I will learn and rebuild my account. Bio stocks are off the table from now on I think. You had good data to pull from compared to posters here. You are just lucky.

The PR gave little chance to retail guys. In an hour all the value was gone. This is pink stock behavior.

Testing $6 my friend. How about that.

The shorts set a wall at $5.93 and the sell volume is holding right now. Hopefully we can break through that wall later today.

I ticked you off because I told folks here not to panic, lol. I lost money before, it always comes back, not a big deal if I die broke either. I just wanna die here in the USA.

how many shares was it?

with good up volume around $6 hopefully.

CJSKI its comical to watch you defend your short tactics against everyone on this board. Have fun with that.

I think the CRL danger has passed.

same here, this is a good ride. I am strapped in tight.

Bill, what I am saying is, don't panic.

890k in shorts

https://ih.advfn.com/stock-market/NASDAQ/sesen-bio-SESN/trades

I am fuzzy on understanding the trades screen on investershub, but it looks like 808,000 in short sales against the buy volume. Who would short to that extent? Losers.

Nothing bad in today's P.R from SESN.
https://www.biopharmcatalyst.com/company/SESN.
Shorts are playing mind games. They have to buy back the shares soon.

To treat Uterine Fibroids its a combo of Ibuprophen and hormone treatments.
I dont see a drug that targets that specific condition
https://www.webmd.com/women/uterine-fibroids/understanding-uterine-fibroids-treatment

Great page, a good effort once again. Durgs.com lists approx 76 drugs for endometriosis https://www.drugs.com/condition/endometriosis.html. As stated there is strong competition but if OBSV is strongly differentiated, they will have a good edge over the field of opponents.

this one is going to test new lows since Nov 2020

I heard the information now. Thanks

Long metal what did Ron say about the timeline for the appeal. I couldnt hear it clearly he mumbled that part. Can you help an old man out!
https://drive.google.com/file/d/1nk2pngN781AQeu9CY0NeZ0TR9OP3I2X2/view

NAK was our worst performer for the month largely from investors' disappointment that NAK's request for appeal on their Pebble Project will take longer than expected.

https://seekingalpha.com/article/4418500-singular-researchs-march-2021-director-letter?utm_source=investorsobserver.com&utm_medium=referral

Hey Bill, it looks like there might be a delay. At the bottom of this article the writer mentions that the NAK Appeal will have a delay but its not very detailed or specific
https://seekingalpha.com/article/4418500-singular-researchs-march-2021-director-letter?utm_source=investorsobserver.com&utm_medium=referral

If we get through today without a PR or even this week I will be much more bullish on the chances of getting a fresh water permit.